Effect of Elastin-derived Peptides on the Production of Tissue Inhibitor of Metalloproteinase-1, -2, and -3 and the Ratios in Various Endothelial Cell Lines

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2015 Jul 3

PMID 26136968

Citations 4

Authors

Krzysztof Siemianowicz

Wirginia Likus

Tomasz Francuz

Wojciech Garczorz

Affiliations

Soon will be listed here.

Abstract

Tissue inhibitors of metalloproteinases (TIMPs) control the activity of metalloproteinases. Elastin-derived peptides (EDPs) are generated as a result of the degradation of elastin fibers. The EDPs bind to the elastin receptor and exert numerous biological effects. The aim of the present study was to compare the production of TIMP-1, TIMP-2 and TIMP-3 and their ratios in human endothelial cells (ECs) derived from three clinically important vascular localizations (coronary arteries, aorta and iliac artery), and evaluate the influence of a well-known EDP, κ-elastin. The highest concentration of TIMP-1 was identified in the aortic ECs, while the lowest concentration was observed in the ECs derived from the coronary artery. The opposite pattern was observed for TIMP-2 production. When the TIMP-3 concentration was analyzed in the three EC lines, no statistically significant differences were observed. Application of κ-elastin was found to decrease the TIMP-1 concentration in the aortic ECs, while an increase in the TIMP-1 concentration was observed in the ECs derived from the iliac artery. The most significant decrease in TIMP-2 concentration following κ-elastin administration was observed in the ECs obtained from the coronary arteries. Furthermore, the highest concentration of κ-elastin resulted in an increase in TIMP-3 production in the ECs derived from the coronary arteries. The following ratios of the TIMP concentrations were calculated: TIMP-1/TIMP-2, TIMP-1/TIMP-3 and TIMP-2/TIMP-3. Each ratio presented different values for the ECs obtained from the various localizations. In the majority of cases, the addition of κ-elastin did not significantly change these proportions. Therefore, these indicators may be characteristic features that can be used to describe ECs in various clinically important vascular localizations.

Citing Articles

Imbalance of Pulmonary Microvascular Endothelial Cell-Expression of Metalloproteinases and Their Endogenous Inhibitors Promotes Septic Barrier Dysfunction.

Jayawardena D, Masciantonio M, Wang L, Mehta S, DeGurse N, Pape C Int J Mol Sci. 2023; 24(9).

PMID: 37175585 PMC: 10178398. DOI: 10.3390/ijms24097875.

Synergistic activation of AMPK by AdipoR1/2 agonist and inhibitor of EDPs-EBP interaction recover NAFLD through enhancing mitochondrial function in mice.

Song N, Xu H, Wu S, Luo S, Xu J, Zhao Q Acta Pharm Sin B. 2023; 13(2):542-558.

PMID: 36873175 PMC: 9978995. DOI: 10.1016/j.apsb.2022.10.003.

Involvement of TIMP-1 in PECAM-1-mediated tumor dissemination.

Abraham V, Cao G, Parambath A, Lawal F, Handumrongkul C, Debs R Int J Oncol. 2018; 53(2):488-502.

PMID: 29845213 PMC: 6017270. DOI: 10.3892/ijo.2018.4422.

The Elastin Receptor Complex: A Unique Matricellular Receptor with High Anti-tumoral Potential.

Scandolera A, Odoul L, Salesse S, Guillot A, Blaise S, Kawecki C Front Pharmacol. 2016; 7:32.

PMID: 26973522 PMC: 4777733. DOI: 10.3389/fphar.2016.00032.

References

Basu P, Qipshidze N, Sen U, Givvimani S, Munjal C, Mishra P . Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery. Arch Physiol Biochem. 2011; 117(5):270-82. PMC: 3235642. DOI: 10.3109/13813455.2011.599844. View

Moore R, Hawley A, Sigler R, Farris D, Wrobleski S, Ramacciotti E . Tissue inhibitor of metalloproteinase-1 is an early marker of acute endothelial dysfunction in a rodent model of venous oxidative injury. Ann Vasc Surg. 2009; 23(4):498-505. DOI: 10.1016/j.avsg.2009.03.005. View

Ramirez Correa G, Zacchigna S, Arsic N, Zentilin L, Salvi A, Sinagra G . Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors. Mol Ther. 2004; 9(6):876-84. DOI: 10.1016/j.ymthe.2004.02.020. View

Ganea E, Trifan M, Laslo A, Putina G, Cristescu C . Matrix metalloproteinases: useful and deleterious. Biochem Soc Trans. 2007; 35(Pt 4):689-91. DOI: 10.1042/BST0350689. View

Troeberg L, Nagase H . Analysis of TIMP expression and activity. Methods Mol Med. 2007; 135:251-67. DOI: 10.1007/978-1-59745-401-8_16. View

Grundy S . Approach to lipoprotein management in 2001 National Cholesterol Guidelines. Am J Cardiol. 2002; 90(8A):11i-21i. DOI: 10.1016/s0002-9149(02)02631-0. View

Seo D, Li H, Guedez L, Wingfield P, Diaz T, Salloum R . TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 2003; 114(2):171-80. DOI: 10.1016/s0092-8674(03)00551-8. View

Shen Q, Lee E, Pitts R, Wu M, Yuan S . Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells. Mol Cancer Res. 2010; 8(7):939-51. PMC: 5584073. DOI: 10.1158/1541-7786.MCR-09-0523. View

Siemianowicz K, Gminski J, Goss M, Francuz T, Likus W, Jurczak T . Influence of elastin-derived peptides on metalloprotease production in endothelial cells. Exp Ther Med. 2012; 1(6):1057-1060. PMC: 3445960. DOI: 10.3892/etm.2010.157. View

10.

Raffetto J, Khalil R . Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 2007; 75(2):346-59. PMC: 2254136. DOI: 10.1016/j.bcp.2007.07.004. View

11.

Seo D, Saxinger W, Guedez L, Cantelmo A, Albini A, Stetler-Stevenson W . An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo. Peptides. 2011; 32(9):1840-8. PMC: 3177407. DOI: 10.1016/j.peptides.2011.08.010. View

12.

Ragino I, Cherniavskii A, Polonskaia I, Volkov A, Kashtanova E, Tsymbal S . [Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood]. Kardiologiia. 2012; 52(5):37-41. View

13.

Robinet A, Fahem A, Cauchard J, Huet E, Vincent L, Lorimier S . Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci. 2005; 118(Pt 2):343-56. DOI: 10.1242/jcs.01613. View

14.

Kallio J, Hopkins-Donaldson S, Baker A, Kahari V . TIMP-3 promotes apoptosis in nonadherent small cell lung carcinoma cells lacking functional death receptor pathway. Int J Cancer. 2010; 128(4):991-6. DOI: 10.1002/ijc.25404. View

15.

George S, Wan S, Hu J, MacDonald R, Johnson J, Baker A . Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation. 2011; 124(11 Suppl):S135-42. DOI: 10.1161/CIRCULATIONAHA.110.012732. View

16.

Mammi C, la Sala A, Volterrani M, Gatta L, Antelmi A, Feraco A . Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure. Eur J Heart Fail. 2011; 13(6):642-50. DOI: 10.1093/eurjhf/hfr026. View

17.

Lemaitre V, Dabo A, DArmiento J . Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling. Toxicol Sci. 2011; 123(2):542-9. PMC: 3179676. DOI: 10.1093/toxsci/kfr181. View

18.

Stetler-Stevenson W . The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2. Cancer Metastasis Rev. 2007; 27(1):57-66. PMC: 2254553. DOI: 10.1007/s10555-007-9105-8. View

19.

Faury G, Garnier S, Weiss A, Wallach J, Fulop Jr T, Jacob M . Action of tropoelastin and synthetic elastin sequences on vascular tone and on free Ca2+ level in human vascular endothelial cells. Circ Res. 1998; 82(3):328-36. DOI: 10.1161/01.res.82.3.328. View

20.

Gminski J, Drozdz M . Succinyl trialanine p-nitroanilide hydrolytic activities in plasma and the aorta of rabbits experimentally immunized with soluble elastin. Exp Pathol. 1991; 43(1-2):37-40. DOI: 10.1016/s0232-1513(11)80139-8. View